Valentino, R. R., Scotton, W. J., Roemer, S. F., Lashley, T., Heckman, M. G., Shoai, M., Martinez-Carrasco, A., Tamvaka, N., Walton, R. L., Baker, M. C., Macpherson, H. L., Real, R., Soto-Beasley, A. I., Mok, K., Revesz, T., Christopher, E. A., DeTure, M., Seeley, W. W., Lee, E. B., … Wszolek, Z. K. (2024). MAPT H2 haplotype and risk of Pick’s disease in the Pick’s disease International Consortium: a genetic association study. The Lancet Neurology, 23(5), 487–499. https://doi.org/10.1016/s1474-4422(24)00083-8

Kim, Y. A., Mellen, M., Kizil, C., & Santa‐Maria, I. (2023). Mechanisms linking cerebrovascular dysfunction and tauopathy: Adding a layer of epiregulatory complexity. British Journal of Pharmacology, 181(6), 879–895. Portico. https://doi.org/10.1111/bph.16280

Rayman, J. B. (2023). Focusing on oligomeric tau as a therapeutic target in Alzheimer’s disease and other tauopathies. Expert Opinion on Therapeutic Targets, 27(4–5), 269–279. https://doi.org/10.1080/14728222.2023.2206561

Du, F., Yu, Q., Kanaan, N. M., & Yan, S. S. (2022). Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer’s disease. Human Molecular Genetics, 31(15), 2498–2507. https://doi.org/10.1093/hmg/ddab363

Guisle, I., Canet, G., Pétry, S., Fereydouni-Forouzandeh, P., Morin, F., Kérauden, R., Whittington, R. A., Calon, F., Hébert, S. S., & Planel, E. (2022). Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia. Neurobiology of Aging, 113, 118–130. https://doi.org/10.1016/j.neurobiolaging.2022.02.011

Chen, S., Acosta, D., Li, L., Liang, J., Chang, Y., Wang, C., Fitzgerald, J., Morrison, C., Goulbourne, C. N., Nakano, Y., Villegas, N. C. H., Venkataraman, L., Brown, C., Serrano, G. E., Bell, E., Wemlinger, T., Wu, M., Kokiko-Cochran, O. N., Popovich, P., … Fu, H. (2022). Wolframin is a novel regulator of tau pathology and neurodegeneration. Acta Neuropathologica, 143(5), 547–569. https://doi.org/10.1007/s00401-022-02417-4